Article Text

Download PDFPDF
212 Is there an ethnicity bias of access to MS services? The barts health experience revisited
  1. Kimberley Allen-Philbey1,
  2. Facundo Silveira3,
  3. Ben Turner1,2,
  4. Gavin Giovannoni1,2,
  5. Klaus Schmierer1,2
  1. 1Clinical Board Medicine, The Royal London Hospital, Barts Health NHS Trust
  2. 2Blizard Institute, Queen Mary University of London
  3. 3Italian Hospital of Buenos Aires, Argentina


Introduction Principle 1 of the NHS constitution states that access to services should be non-discriminatory including ethnic background. Early diagnosis and initiation of disease modifying treatment (DMT) in people with multiple sclerosis (pwMS) is important for prognosis. We report findings from a re-audit of ethnic equity of clinical service experience in pwMS in east London.

Methods Retrospective cohort of pwMS ≥18 years old, diagnosed between 2014–2017 with 2 years of follow-up, attending Neurology services at Barts Health NHS Trust. We compared access to MS services between ethnic groups. Result variables included (i) first symptom to diagnosis (S2D) and (ii) diagnosis to DMT (D2T).

Results 59 pwMS fulfilled inclusion criteria, 7/59 were Black, 13/59 South Asian, 22/59 White and 17/59 as Other. There was a non-significant trend towards shorter S2D in White pwMS (1.2 years) compared to the other groups (Black 1.94, South Asian 1.93 and Other 1.55) (p=0.54). No difference was observed regarding D2T (Black 0.51 years, South Asian 0.31, White 0.58 and Other 0.47, p=0.25).

Conclusion Reassuringly, no ethnic inequity of access to MS services was detected, confirming findings of the original audit.

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.